Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach

被引:14
作者
Agic, Dejan [1 ]
Brkic, Hrvoje [2 ]
Tomic, Sanja [3 ]
Karacic, Zrinka [3 ]
Spoljarevic, Marija [1 ]
Lisjak, Miroslav [1 ]
Beslo, Drago [1 ]
Abramic, Marija [3 ]
机构
[1] Josip Juraj Strossmayer Univ Osijek, Fac Agr Osijek, Osijek, Croatia
[2] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia
[3] Rudjer Boskovic Inst, Zagreb, Croatia
关键词
dipeptidyl peptidase III; flavonoids; inhibitory activity; metallopeptidase; molecular dynamics; AMIDINO-SUBSTITUTED BENZIMIDAZOLES; ENKEPHALIN-DEGRADING ENZYMES; AMINOPEPTIDASE-III; ENDOGENOUS INHIBITOR; PROTEINS; BINDING; METALLOPEPTIDASES; PURIFICATION; SIMULATION; MECHANISM;
D O I
10.1111/cbdd.12887
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fifteen flavonoids were studied for their inhibitory activity against human dipeptidyl peptidase III (hDPP III) combining an in vitro assay with an in silico molecular modeling study. All analyzed flavonoids showed inhibitory effects against hDPP III with the IC50 values ranging from 22.0 to 437.2 mu m. Our 3D QSAR studies indicate that the presence of hydrophilic regions at a flavonoid molecule increases its inhibitory activity, while the higher percentage of hydrophobic surfaces has negative impact on enzyme inhibition. Furthermore, molecular dynamics (MD) simulations of the complex of hDPP III with one of the most potent inhibitors, luteolin, were performed, and binding mode analysis revealed that the 3' and 4' hydroxyl group on B-ring as well as 5 and 7 hydroxyl group on A-ring helps luteolin to interact with the Asn391, Asn406, Tyr417, His450, Glu451, Val447, Glu512, Asn545, Gln566, and Arg572 residues. The MD results clearly provide valuable information explaining the importance of flavonoid hydroxyl groups in the mechanism for the binding pattern at the active site of hDPP III.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 48 条
  • [1] DIPEPTIDYL PEPTIDASE-III FROM HUMAN-ERYTHROCYTES
    ABRAMIC, M
    ZUBANOVIC, M
    VITALE, L
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (01): : 29 - 38
  • [2] Abramic M, 2004, PERIOD BIOL, V106, P161
  • [3] Novel amidino-substituted benzimidazoles: Synthesis of compounds and inhibition of dipeptidyl peptidase III
    Agic, Dejan
    Hranjec, Marijana
    Jajcanin, Nina
    Starcevic, Kristina
    Karminski-Zamola, Grace
    Abramic, Marija
    [J]. BIOORGANIC CHEMISTRY, 2007, 35 (02) : 153 - 169
  • [4] Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins
    Barsun, Marina
    Jajcanin, Nina
    Vukelic, Bojana
    Spoljaric, Jasminka
    Abramic, Marija
    [J]. BIOLOGICAL CHEMISTRY, 2007, 388 (03) : 343 - 348
  • [5] Mechanism of auxin interaction with auxin binding protein (ABP1): A molecular dynamics simulation study
    Bertosa, Branimir
    Kojic-Prodic, Biserka
    Wade, Rebecca C.
    Tomic, Sanja
    [J]. BIOPHYSICAL JOURNAL, 2008, 94 (01) : 27 - 37
  • [6] Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase III
    Bezerra, Gustavo A.
    Dobrovetsky, Elena
    Viertlmayr, Roland
    Dong, Aiping
    Binter, Alexandra
    Abramic, Marija
    Macheroux, Peter
    Dhe-Paganon, Sirano
    Gruber, Karl
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (17) : 6525 - 6530
  • [7] Bormann H, 2000, PHARMAZIE, V55, P129
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] Case D., 2014, AMBER, V14
  • [10] Chen J.-M., 2004, HDB PROTEOLYTIC ENZY, V1, P80912